Urology Supplements Market Share, Size, Trends, Industry Analysis Report, By Type (Multi-ingredient, Single-ingredient); By Application; By Formulation; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

Urology Supplements Market Share, Size, Trends, Industry Analysis Report, By Type (Multi-ingredient, Single-ingredient); By Application; By Formulation; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

The global urology supplements market size is expected to reach USD 4.16 billion by 2032, according to a new study by Polaris Market Research. The report “Urology Supplements Market Share, Size, Trends, Industry Analysis Report, By Type (Multi-ingredient, Single-ingredient); By Application; By Formulation; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing focus on developing prominent health supplements for the treatment of urology-based health problems is positively driving the global market. The presence of established healthcare regulators is enhancing consumer safety. For instance, in November 2023, after successful clinical trials, the United Nations Food and Drug Administration announced the approval of Enzalutamide for the treatment of prostate cancer in a Nonmetastatic Hormone-Sensitive setting.

As per the statistics published by the Centers for Disease Control and Prevention (CDC), nearly 37 Mn individuals in the U.S. were living with chronic kidney disease (CKD), while 726,000 have end-stage CKD. Moreover, in June 2023, Somatus & Kidney Care Center extended their partnership to promote accessibility to customized resources & support for

Global urology supplements are witnessing increased demand, with charging individuals' eating patterns driven by the availability of several ultra-processed and convenience foods. According to the 2023 study published in Nature Review Urology magazine, obesity can lead to mortality and aggressive and high-grade prostate cancer among individuals. The limited time for preparing meals at home and the lack of regular exercise due to the hectic work schedules among the households are major factors causing obesity, thereby causing prostate cancer and other kidney-related health issues among people.

The rising number of prostate cancer cases in developed countries is becoming a huge difficulty for the government, primarily in the United States and the U.K. According to Cancer Research U.K., the penetration rate of prostate cancer is expected to grow by 15% from 2023-2025 and 2038-2040.

People are showing interest in preventive care in the marketplace with a view to safeguarding themselves from deadly diseases. This is forcing pharmaceutical companies to formulate preventive care medications. For instance, in January 2024, Theralogix unveiled its new supplement, Mannose One, to prevent the incidence of urinary tract infections by removing the attachment of bacteria to the bladder lining.

Urology Supplements Market Report Highlights

Multi-ingredient segment is anticipated to witness the highest growth due to the growing use of multiple ingredients to formulate effective supplements.

Urinary tract infections segment accounted for the largest market share owing to the increasing prevalence of urinary tract infections, primarily among women.

In 2023, the North America region held the largest market share, the region boasts advanced healthcare infrastructure, including robust distribution networks, well-established healthcare facilities, and a strong regulatory framework.

APAC is projected to register the fastest growth, attributable to the increasing expansion activities by the market players.

The global players include Biotex Life, Himalayan Organics, Himalaya Wellness, Natrol, LLC., Nature's Bounty, Puritan's Pride, Schiff Nutrition, Solaray, etc.

Polaris Market Research has segmented the urology supplements market report based on type, application, formulation, distribution channel, and region:

Urology Supplements, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Multi-ingredient

Single-ingredient

Urology Supplements, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Urinary Tract Infections

Kidney Health

Prostate Health

Bladder Health

Urology Supplements, Formulation Outlook (Revenue - USD Billion, 2019 - 2032)

Capsules

Softgels

Tablets

Liquid

Others

Urology Supplements, Distribution Channel Outlook (Revenue - USD Billion, 2019 -

E-commerce

Brick & Mortar

Urology Supplements, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Mexico

Rest of LA

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA